214
Views
20
CrossRef citations to date
0
Altmetric
Notes

A new 3,4-seco-labdane diterpenoid with inhibitory activity against the production of nitric oxide from the leaves of Callicarpa nudiflora

, , , , , , & show all
Pages 216-221 | Received 08 May 2013, Accepted 04 Sep 2013, Published online: 20 Nov 2013
 

Abstract

A new 3,4-seco-labdane diterpenoid, 3,4-seco-12R,13S-dihydroxy-4(18),8(17),14(15)-labdatrien-3-oic acid (1), was isolated from the leaves of Callicarpa nudiflora. The structure of 1 was elucidated by 1D NMR, 2D NMR and HRESIMS data, and confirmed by single-crystal X-ray diffraction analysis. 3,4-seco-12R,13S-Dihydroxy-4(18),8(17),14(15)-labdatrien-3-oic acid (1) exerted inhibitory activity against the production of nitric oxide in RAW264.7 stimulated by lipopolysaccharide.

Acknowledgements

Financial support of National Natural Science Foundation (Grant No. 81060367) and National Key Technology R&D Program (Grant No. 2011BAI01B07) are gratefully acknowledged. We thank for Ms Wen Li and Mr Yi Sha of Analysis & Testing Centers of Shenyang Pharmaceutical University for the NMR data measurements. We gratefully acknowledge the Hainan Jiuzhitang Co., Ltd for the collection of the plant material. We also thank Professor Weiping Chen of Chinese Academy of Medical Sciences, Hainan Union Medical College Institute of Medical Plant Development for identification of the plant material.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.